Related Articles
Epidermal growth factor receptor analyses in colorectal cancer: A comparison of methods
HER-2/neu gene amplification by fluorescence in situ hybridization allows risk-group assessment in node-negative breast cancer.
Prognostic utility of fluorescence in situ hybridization for determining HER2 gene amplification in breast cancer
Amplification of the human epidermal growth factor receptor 2 gene in differentiated thyroid cancer correlates with telomere shortening
Relationship between HER2 status and proliferation rate in breast cancer assessed by immunohistochemistry, fluorescence in situ hybridisation and standardised AgNOR analysis